Kiniksa Pharmaceuticals International, plc Quarterly Contract with Customer, Liability, Current in USD from Q3 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: Kiniksa Pharmaceuticals International, plc quarterly Contract with Customer, Liability, Current history and growth rate from Q3 2022 to Q2 2024.
Kiniksa Pharmaceuticals International, plc Contract with Customer, Liability, Current for the quarter ending June 30, 2024 was $12K, a 99.7% decline year-over-year.

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$12K	-$4.66M	-99.7%	Jun 30, 2024	10-Q	2024-07-25
Q1 2024	$156K	-$6.34M	-97.6%	Mar 31, 2024	10-Q	2024-04-25
Q4 2023	$307K			Dec 31, 2023	10-Q	2024-10-29
Q3 2023	$2.56M	-$9.53M	-78.8%	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$4.67M			Jun 30, 2023	10-Q	2023-08-01
Q1 2023	$6.5M			Mar 31, 2023	10-Q	2023-05-04
Q3 2022	$12.1M			Sep 30, 2022	10-Q	2022-11-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.